INTL MEDICATION FDA Approval ANDA 070639

ANDA 070639

INTL MEDICATION

FDA Drug Application

Application #070639

Application Sponsors

ANDA 070639INTL MEDICATION

Marketing Status

Prescription001

Application Products

001INJECTABLE;INJECTION0.4MG/ML0NALOXONE HYDROCHLORIDENALOXONE HYDROCHLORIDE

FDA Submissions

ORIG1AP1986-01-17
LABELING; LabelingSUPPL2AP1986-09-09
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1987-02-06
LABELING; LabelingSUPPL4AP1988-05-20
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1993-10-29
MANUF (CMC); Manufacturing (CMC)SUPPL8AP1998-01-14
MANUF (CMC); Manufacturing (CMC)SUPPL9AP1994-06-17
LABELING; LabelingSUPPL10AP1995-02-09
MANUF (CMC); Manufacturing (CMC)SUPPL11AP1995-09-19
LABELING; LabelingSUPPL12AP1996-06-10
MANUF (CMC); Manufacturing (CMC)SUPPL13AP2002-07-18
LABELING; LabelingSUPPL14AP2002-07-18
MANUF (CMC); Manufacturing (CMC)SUPPL16AP2015-05-29
LABELING; LabelingSUPPL17AP2013-07-26STANDARD

Submissions Property Types

SUPPL1Null0
SUPPL3Null0
SUPPL7Null0
SUPPL8Null0
SUPPL9Null0
SUPPL11Null0
SUPPL13Null0
SUPPL16Null7
SUPPL17Null7

TE Codes

001PrescriptionAP

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 70639
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.